Buhlak, S. Et Al. 2025. Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme. Pharmaceuticals , vol.18, no.2 .

Buhlak, S., Abad, N., Akachar, J., Saffour, S., Kesgun, Y., Dik, S., ... Yasin, B.(2025). Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme. Pharmaceuticals , vol.18, no.2.

Buhlak, Shafeek Et Al. "Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme," Pharmaceuticals , vol.18, no.2, 2025

Buhlak, Shafeek Et Al. "Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme." Pharmaceuticals , vol.18, no.2, 2025

Buhlak, S. Et Al. (2025) . "Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme." Pharmaceuticals , vol.18, no.2.

@article{article, author={Shafeek Buhlak Et Al. }, title={Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme}, journal={Pharmaceuticals}, year=2025}